Birchview Capital as of Sept. 30, 2022
Portfolio Holdings for Birchview Capital
Birchview Capital holds 60 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bristol Myers Squibb (BMY) | 36.4 | $52M | 728k | 71.09 | |
| Aziyo Biologics (ELUT) | 7.2 | $10M | 1.4M | 7.20 | |
| Neurocrine Biosciences (NBIX) | 6.4 | $9.1M | 85k | 106.21 | |
| Prothena Corp SHS (PRTA) | 5.1 | $7.2M | 119k | 60.63 | |
| Quidel Corporation | 3.1 | $4.4M | 61k | 71.48 | |
| ACADIA Pharmaceuticals (ACAD) | 2.9 | $4.1M | 249k | 16.36 | |
| Encana Corporation (OVV) | 2.7 | $3.9M | 84k | 46.00 | |
| Accelr8 Technology | 2.4 | $3.4M | 2.3M | 1.52 | |
| United Therapeutics Corporation (UTHR) | 2.2 | $3.1M | 15k | 209.40 | |
| Biodesix (BDSX) | 2.1 | $3.0M | 2.4M | 1.27 | |
| Continental Resources | 1.8 | $2.6M | 39k | 66.81 | |
| Foghorn Therapeutics (FHTX) | 1.6 | $2.3M | 265k | 8.58 | |
| Albireo Pharma | 1.6 | $2.3M | 117k | 19.36 | |
| Biohaven Pharmaceutical Holding | 1.6 | $2.2M | 15k | 151.19 | |
| Harrow Health (HROW) | 1.5 | $2.2M | 180k | 12.07 | |
| Masimo Corporation (MASI) | 1.5 | $2.2M | 15k | 141.16 | |
| Phreesia (PHR) | 1.5 | $2.1M | 83k | 25.48 | |
| Gossamer Bio (GOSS) | 1.3 | $1.9M | 159k | 11.98 | |
| Ventyx Biosciences (VTYX) | 1.1 | $1.6M | 45k | 34.91 | |
| Karyopharm Therapeutics (KPTI) | 1.0 | $1.5M | 269k | 5.46 | |
| Corcept Therapeutics Incorporated (CORT) | 0.9 | $1.3M | 50k | 25.64 | |
| Inhibrx (INBX) | 0.9 | $1.3M | 70k | 17.96 | |
| Cytokinetics (CYTK) | 0.9 | $1.2M | 25k | 48.44 | |
| Aveo Pharmaceuticals | 0.8 | $1.2M | 140k | 8.23 | |
| Alkermes SHS (ALKS) | 0.8 | $1.1M | 50k | 22.34 | |
| Docgo (DCGO) | 0.8 | $1.1M | 110k | 9.92 | |
| Chemocentryx | 0.7 | $1.0M | 20k | 51.65 | |
| Equitrans Midstream Corp (ETRN) | 0.7 | $995k | 133k | 7.48 | |
| 2seventy Bio (TSVT) | 0.6 | $871k | 60k | 14.56 | |
| Pioneer Natural Resources (PXD) | 0.6 | $823k | 3.8k | 216.58 | |
| Apellis Pharmaceuticals (APLS) | 0.6 | $820k | 12k | 68.33 | |
| Inari Medical Ord (NARI) | 0.5 | $726k | 10k | 72.60 | |
| ImmunoGen | 0.5 | $717k | 150k | 4.78 | |
| Arvinas Ord (ARVN) | 0.5 | $667k | 15k | 44.47 | |
| Bluebird Bio (BLUE) | 0.4 | $620k | 98k | 6.33 | |
| Kalvista Pharmaceuticals (KALV) | 0.4 | $580k | 40k | 14.50 | |
| Irhythm Technologies (IRTC) | 0.4 | $501k | 4.0k | 125.25 | |
| G1 Therapeutics (GTHX) | 0.4 | $500k | 40k | 12.50 | |
| Silk Road Medical Inc Common (SILK) | 0.3 | $450k | 10k | 45.00 | |
| Iveric Bio | 0.3 | $449k | 25k | 17.96 | |
| Nektar Therapeutics (NKTR) | 0.3 | $410k | 128k | 3.20 | |
| Soleno Therapeutics | 0.3 | $409k | 245k | 1.67 | |
| Amicus Therapeutics (FOLD) | 0.3 | $397k | 38k | 10.45 | |
| Kiniksa Pharmaceuticals (KNSA) | 0.3 | $385k | 30k | 12.83 | |
| Xenon Pharmaceuticals (XENE) | 0.3 | $361k | 10k | 36.10 | |
| Cullinan Oncology (CGEM) | 0.2 | $322k | 25k | 12.82 | |
| Protagonist Therapeutics (PTGX) | 0.2 | $320k | 38k | 8.42 | |
| Xencor (XNCR) | 0.2 | $320k | 12k | 26.02 | |
| Sarepta Therapeutics (SRPT) | 0.2 | $276k | 2.5k | 110.40 | |
| BioCryst Pharmaceuticals (BCRX) | 0.2 | $252k | 20k | 12.60 | |
| Stoke Therapeutics (STOK) | 0.1 | $193k | 15k | 12.87 | |
| Inflarx Nv (IFRX) | 0.1 | $185k | 70k | 2.64 | |
| Concert Pharmaceuticals I equity | 0.1 | $134k | 20k | 6.70 | |
| Alphatec Holdings (ATEC) | 0.1 | $87k | 10k | 8.70 | |
| Yield10 Bioscience | 0.0 | $56k | 19k | 2.99 | |
| Laird Superfood (LSF) | 0.0 | $51k | 28k | 1.82 | |
| Angion Biomedica Corp | 0.0 | $50k | 54k | 0.92 | |
| Contrafect | 0.0 | $34k | 200k | 0.17 | |
| Sientra | 0.0 | $26k | 40k | 0.65 | |
| Aspira Womens Health | 0.0 | $22k | 60k | 0.37 |
